Introduction
The cyclin-dependent kinase inhibitor p21 (Waf1/Cip1) binds and inhibits Cdk/Cyclin complexes that regulate the G1 to S phase transition of the cell cycle, and it plays an essential role in p53-mediated growth arrest following DNA damage (Brugarolas et al., 1995; Deng et al., 1995) . p21 also contributes to the maintenance of cell cycle arrest in G2 (Bunz et al., 1998; Niculescu et al., 1998) , and binds and inhibits proliferating cell nuclear antigen (PCNA), an auxiliary factor for DNA polymerases (Luo et al., 1995) . Expression of p21 is transcriptionally regulated by the tumor suppressor p53 following DNA damage, and by many p53-independent mechanisms (reviewed in Gartel and Tyner, 1999) .
While the gene encoding p21 is rarely mutated in human cancers, a variety of studies suggest a tumor suppressor function for p21. Mice lacking p21 were found to be more prone to developing malignant skin tumors following carcinogen treatment (Philipp et al., 1999; Topley et al., 1999) . Aging p21-deficient mice developed spontaneous tumors by 16 months of age, in comparison with 20 months for wild-type animals, with the majority of these being of hematopoietic origin (Martin-Caballero et al., 2001) . Disruption of the p21 gene enhanced colon tumor formation in mice with mutations in APC (Yang et al., 2001) . Following a single dose of g-irradiation, p21-deficient mice developed more tumors and these tumors had increased metastatic potential (Jackson et al., 2003) .
Colorectal cancer is the second leading cause of cancer-related deaths in the United States. To explore the role of p21 as a potential tumor suppressor in the colon, we examined the formation of dysplastic aberrant crypt foci (ACF) in wild-type and p21-deficient mice following injection of the colon carcinogen azoxymethane (AOM). Higher numbers of ACF are detected in colon cancer patients than in patients with noncancerous lesions, suggesting that ACF are precursors of adenomas (Takayama et al., 1998) . A significant increase in the formation of ACF in p21-deficient mice supported a tumor suppressor function for p21 in the colon, and led us to investigate the epithelial cell intrinsic and extrinsic factors that contribute to enhanced ACF formation in vivo.
Results
AOM is a DNA alkylating agent and a potent carcinogen used to induce colon tumors in rodents (Feinberg and Zedeck, 1980) . ACF are focal lesions that arise prior to the development of tumors in response to AOM injection, and these can be visualized in methylene blue-stained colon, as crypt regions are larger than normal crypts and have a thicker epithelial lining (Bird et al., 1989) . ACF may arise as single or multiple aberrant crypts in a cluster. Wild-type and p21-deficient mice were injected with AOM for 6 weeks and killed at 10 weeks following initiation of the AOM injections.
Colons were removed and stained with methylene blue and three individuals counted ACF from the rectum to the cecum in 14 animals per each genotype. A striking increase in ACF formation was detected in colons of p21-deficient mice (Figure 1a) . In contrast to wild-type animals, ACF in p21-deficient mice were distributed throughout the colon and not restricted to the distal three centimeters (Figure 1b) . Typical ACF in a methylene blue-stained colon are shown in Figure 1c , and a section through an ACF composed of multiple crypts is shown in Figure 1d .
p21 is expressed in a p53-independent manner during the normal differentiation of intestinal epithelial cells in vivo and in vitro (Macleod et al., 1995; Gartel et al., 1996) . In addition, p21 may be activated by p53 after DNA damage (Gartel and Tyner, 1999) . Others have reported that levels of p53 increase 3-6 h after AOM injection, but activation of p53 targets in colon is subdued perhaps because of decreased expression of the coactivator p300 (Aizu et al., 2003) . We examined p21 protein expression in the wild-type untreated mouse colon, and at 6 and 72 h post AOM injection (Figure 2 ). p21 levels were not significantly elevated at the 6 h time point. However, a modest, but significant increase in p21 expression was detected by 72 h, indicating that p21 regulation is sensitive to the AOM-induced changes in the colon (Po0.02).
To begin to identify mechanisms by which p21-deficiency leads to increased numbers of ACF, we examined epithelial cell proliferation and apoptosis in colons of mice after AOM injection. Deregulation of proliferation and/or apoptosis may contribute to the development of cancer (reviewed in Evan and Vousden, 2001) . A previous report indicated that increased Figure 1 Increased ACF formation is detected in colons of p21-deficient mice after AOM treatment. (a) p21-deficient mice develop significantly more ACF after AOM treatment than wild-type mice (*Po0.05). A total of 14 animals per genotype were examined for ACF formation at 10 weeks after the initiation of AOM injections. ACF were counted in methylene blue-stained whole colon. (b) ACF develop throughout the colon in p21-deficient mice. ACF were counted along the proximal (cecum) to distal axis (rectum) of the colon. Wild-type mice developed ACF only within the first 3 cm of the distal colon, while ACF were distributed throughout the length of the colon in p21À/À mice. epithelial apoptosis and proliferation would be observed at 6 and 72 h, respectively, in rodents, after AOM injection (Hirose et al., 1996) . 5-Bromo-2 0 -deoxyuridine (BrdU) was administered 2 h before the animals were killed, and BrdU incorporation in the colons of wildtype and p21-deficient mice was examined using immunohistochemistry. As reported, BrdU incorporation increased at 72 h post AOM injection. However, no significant difference in BrdU incorporation between the two genotypes was detected before or after administration of AOM (Figure 3a) .
To further examine cell cycle regulation after AOM injection, protein lysates were prepared and expression of PCNA, Cyclin D1, and Cyclin A was examined. Disruption of the p21 gene did not result in increased expression of these proliferation markers (Figure 3b ). These data correlate well with our inability to detect significant differences in BrdU incorporation, and suggest that increased cell proliferation is not a major contributing factor to enhanced ACF formation in p21-deficient mice.
It has been recognized that apoptosis is an important mechanism by which colonic stem cells bearing deleterious mutations may be eliminated following exposure to chemical carcinogens (Potten et al., 1992) . Apoptosis occurs following injection of a single dose of AOM in rodents (Hirose et al., 1996) , and peak levels of apoptosis have been reported at 6 h after AOM injection in mice (Aizu et al., 2003) . To examine apoptosis in the colon in response to AOM, antibodies specific for cleaved Caspase-3 were used to detect activation of Caspase-3 in situ in untreated mice, and at 6, 8, and 72 h after a single AOM injection. Cleaved Caspase-3 positive cells were detected at highest numbers in wildtype colon at the 6-h time point. Significant cleaved Caspase-3 immunoreactivity was not detected in the p21-deficient colon at any time point examined ( Figure  4a and b) .
To further compare the levels of apoptosis in wildtype and p21-deficient mice, TUNEL assays were performed with colon tissue isolated at 0, 6, 8, and 72 h after AOM injection. Caspase-3 activation occurs before DNA fragmentation and the peak of TUNEL labeling occurred at 8 h in wild-type animals. Although many TUNEL-positive cells were detected in wild-type colon, only a few labeled cells were present in p21-deficient colons ( Figure 5 ). We detected decreased apoptosis in the colons of p21-null mice using two separate methods. The decreased apoptosis in the p21-deficient colon may contribute to further development of focal lesions following AOM injection.
After killing animals at 10 weeks following the initiation of AOM treatment, increased numbers of lymphoid aggregates were detected throughout the colons of treated p21-deficient mice (Figure 6a ). No increase in lymphoid tissue was detected in p21-deficient mice injected with saline, when compared with salineinjected wild-type control animals. Like the ACF in p21- Figure 3 Similar levels of cell proliferation are detected in wild-type and p21-deficient colons after AOM injection. (a) BrdU incorporation was measured in wild-type and p21-deficient colon using immunohistochemistry followed by image analysis using NIH Image software. Relative numbers of BrdU-positive cells per field are indicated. While there is a trend toward increased BrdU incorporation by 72 h after AOM injection in both genotypes, no significant difference was detected between numbers of BrdU-positive cells in wild-type and p21-deficient mouse colons. Bar represents the mean7s.d. (b) Disruption of the p21 gene does not alter expression of cell cycle regulators in the colon. Similar levels of PCNA, Cyclin D1, and Cyclin A protein are observed in wild-type and p21-deficient colon following AOM injection. Protein lysates from three animals/genotype/time point after AOM injection were separated on SDS-polyacrylamide gels and immunoblotting was performed with the indicated antibodies. To confirm equal loading of proteins on the gel, the membrane was probed with antibody against b-actin p21 provides resistance to the colon carcinogen azoxymethane AJ Poole et al null mice, lymphoid aggregates were detected macroscopically and microscopically throughout the length of the colon from the rectum to the cecum. Typical hematoxylin and eosin-stained lymphoid aggregates are shown in Figure 6b .
Discussion
Expression of p21 increases in differentiating colon epithelial cells in vitro, and is localized to nonproliferating, differentiating epithelial cells in the healthy adult colon (Gartel et al., 1996) . In chimeric mice, migrationassociated differentiation of p21-deficient small intestinal epithelial cells was grossly normal (Brugarolas et al., 1995) . However, induced expression of p21 in a colorectal carcinoma cell line resulted in growth arrest and induction of differentiation marker expression, suggesting close coupling of cell cycle exit and differentiation programs (van de Wetering et al., 2002) . Our studies did not identify differences in cell proliferation or expression of proteins regulated during cell cycle progression, suggesting that the putative tumor suppressor function of p21 in the colon is not correlated with regulation of epithelial cell turnover. Figure 5 Increased apoptosis-induced DNA fragmentation is detected in wild-type mice when compared with p21-deficient mice after AOM injection. The TUNEL method was used to detect DNA fragmentation in colon sections from wild-type and p21-deficient mice at 0, 6, 8, and 72 h post AOM injection, and TUNEL-positive cells were observed at 6 and 8 h post AOM injection (shown). Highest numbers of TUNEL-positive cells were detected at 8 h in wild-type colon (FITC labeled, green). All photos were taken at the same magnification and the bar represents 100 mm Figure 4 Caspase-3 cleavage is detected in wild-type colonic epithelium at 6 h following AOM injection. In order to examine apoptosis, immunohistochemistry was performed with antibodies against cleaved Caspase-3 and colon sections from wild-type and p21-deficient mice. (a) Cleaved Caspase-3 was detected in wild-type colon, but not in p21-deficient colon at 6 h post AOM injection. Top and middle panels show different magnifications of the same sections from wild-type and p21-deficient mice. Caspase-3 antibody binding was visualized using FITC (green), and nuclei were stained with DAPI (blue). Bars represent 20 mm. (b) Immunohistochemistry was performed with antibodies against cleaved Caspase-3 and colon sections from wild-type and p21-deficient mice at 0, 6, 8, and 72 h post AOM injection. White arrowheads point out cleaved Caspase-3-positive cells in the wild-type colon at 6 h post AOM injection. The green signal at the surface is debris. All photos were taken at the same magnification and the bar represents 50 mm p21 provides resistance to the colon carcinogen azoxymethane AJ Poole et al
Apoptosis provides an important protective mechanism for disposing of damaged cells that may escape growth control. In the AOM model, apoptosis was greatly reduced in p21-deficient mice in response to AOM treatment, when compared with wild-type mice. These data suggest that p21 expression in the wild-type colon facilitates apoptosis of damaged cells. Although generally viewed as an inhibitor of apoptosis (reviewed in Gartel and Tyner, 2002) , targeted overexpression of p21 expression has been shown to enhance apoptosis in some systems (Sheikh et al., 1995; Kadowaki et al., 1999; Kang et al., 1999; Tsao et al., 1999; Lincet et al., 2000; Goke et al., 2001) . Disruption of p21 expression has also been shown to lead to decreased cell death (Chinery et al., 1997; Hingorani et al., 2000; Kwon et al., 2003) . The contribution of p21 to cell death may be dependent on the cell type and the nature of insult to which the cells are subjected.
Gut-associated lymphoid tissue (GALT) includes lymphocytes residing in Peyer's patches, lamina propria, and intraepithelial compartments, and resident eosinophils (Rothenberg et al., 2001) . We detected an increase in the number of lymphoid follicles in the colons of p21-deficient mice after AOM treatment. In mice, an increase in lymphoid tissue in the distal colon was correlated with development of overt tumors following AOM administration (Carter et al., 1994) . It is well recognized that patients with inflammatory bowel disease have a higher risk for developing colon cancer (reviewed in Rhodes and Campbell, 2002) . The increase in lymphoid tissue in p21-deficient mice may play a substantial role in growth and development of the ACF.
Different aspects of hematopoiesis are sensitive to p21 and may contribute to an increase in lymphoid tissue in the colon. An increase in the homeostatic hematopoietic stem cell pool was detected in mice lacking p21, suggesting that p21 is important for the maintenance of hematopoietic stem cell quiescence (Cheng et al., 2000) . It has been shown that p21 may control T-cell proliferation, and some strains of female p21-deficient mice have decreased viability and develop a syndrome similar to human lupus (Balomenos et al., 2000) . Interestingly, a reduction in apoptosis has also been detected in T lymphocytes lacking p21 (Hingorani et al., 2000) . Thus, increased expansion of a precursor pool and decreased programmed cell death could give rise to increased lymphoid tissue in p21-deficient mice.
We found that administration of AOM had pleiotropic effects in animals with a germline mutation in the p21 gene. Decreased colonic epithelial cell apoptosis and increased production of lymphoid tissue may both contribute to the increased ACF formation in AOMtreated p21-deficient animals. Patients with colorectal tumors that expressed p21 had a greater response to systemic chemotherapy (Cheng et al., 1999) , suggesting that p21 expression may also enhance apoptosis at some point during the course of cancer treatment. Determining the mechanisms underlying the ability of p21 to suppress or enhance apoptosis under different physiological conditions will clarify its role as a potential therapeutic target.
Materials and methods

Animals
Genetically matched wild-type and p21À/À female littermates, 12-18 weeks of age were used for all experiments (Kwon et al., 2002) . Genomic DNA isolation and PCR were used to confirm genotypes of the mice. Mice were housed in the same room under controlled conditions, including a 12 h light/dark cycle, with ad libitum access to diet and water. Wild-type and p21-deficient animals received injections of AOM in sterile saline solution at the dose of 10 mg/kg body weight subcutaneously once a week for 6 weeks. In parallel, control animals received saline injections. Animals were killed 4 weeks after the last AOM injection. For the apoptosis and proliferation studies, animals were injected with 15 mg/kg AOM intraperitoneally (i.p.) and killed 6, 8, or 72 h later. Mice were injected i.p. with 50 mg of BrdU (Sigma, Saint Louis, MO, USA) per gram of mice body weight 2 h before killing. Figure 6 Increased numbers of lymphoid aggregates in p21-deficient mice following AOM injection. (a) Serial sections of colons from wild-type and p21-deficient mice were stained and lymphoid aggregates were counted. A significant increase in lymphoid aggregates was observed in p21-deficient mice only after the treatment with AOM. (b) Lymphoid aggregates are readily detected in sections of hematoxylin and eosin-stained p21-deficient proximal and distal colon (arrows). All photos were taken at the same magnification and the bar represents 100 mm p21 provides resistance to the colon carcinogen azoxymethane AJ Poole et al
Identification of ACF and lymphoid aggregates
Colons were removed, opened and flattened between two glass slides and fixed in 70% ethanol. They were then stained with methylene blue and the total number of ACF were counted using transillumination and light microscopy (Paulsen et al., 2001) . ACF were larger than adjacent normal crypts, with thickened epithelia and an altered luminal opening (Bird et al., 1989) . After counting ACF, colons were divided into proximal and distal portions and embedded in paraffin blocks. Serial sections were used for hematoxylin and eosin staining and microscopic lymphoid aggregate scoring.
Immunoblotting
Total cell lysates (50 mg) from colons were separated by SDS-PAGE and transferred to polyvinylidene difluoride membrane. Prior to immunoblotting, membranes were stained with Ponceau S to confirm equal loading and transfer of protein.
Immunoblotting was performed with anti-Cyclin A (C-19) and anti-PCNA-HRP (PC10) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), anti-Cyclin D1(DCS-6) (NeoMarkers, Inc., Fremont, CA, USA), anti-p21 (556431) (BD Biosciences Pharmingen, San Diego, CA, USA) and anti-b-actin (Sigma, Saint Louis, MO, USA). Quantitation of band intensity was performed using Kodak 1D image analysis software (Eastman Kodak, Rochester, NY, USA).
Immunohistochemistry and TUNEL assays
The M.O.M. kit (Vector Laboratories, Burlingame, CA, USA) was used prior to incubating sections with primary mouse monoclonal antibody against BrdU at a 1 : 100 dilution (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA). BrdU incorporating cells were quantitated using the image processing and analysis program, NIH Image (1.63) (NIH, Bethesda, MD, USA).
To examine cleaved Caspase-3 expression, paraffin-embedded tissue sections were pretreated for antigen recovery by microwave heating in 0.01 M citrate (pH 6.0) and incubated with rabbit polyclonal cleaved Caspase-3 antibody (Asp-175, Cell Signaling Technology, Beverly, MA, USA) at 1 : 100 dilution as recommended by the manufacturer.
TUNEL assays were performed using the In Situ Cell Death Detection Kit (Roche Diagnostics Corp., Indianapolis, IN, USA) according to the manufacturer's instructions. TUNELpositive apoptotic cells were labeled with fluorescein isothiocyanate (FITC, green), and 4,6 diamidino-2-phenylindole (DAPI) was used to stain nuclei (blue).
Statistical analyses
The average incidence of ACF was calculated for each 1 cm segment beginning at the distal end and continuing up the length of the colon to the cecum. The total number of ACF for each group was analysed for significant difference using the Mann-Whitney rank test. A difference was considered statistically significant when the P-value was 0.05 or less.
Results from AOM treatment of wild-type and p21-deficient mice were statistically analysed using SAS8.0 (SAS institute Inc., Cary, NC, USA) software.
Abbreviations ACF, aberrant crypt foci; AOM, azoxymethane.
